Your ADHD, Finally Measured.
Continuous wrist biometrics — fidget frequency, HRV, attention cycling — delivering clinical-grade data to the providers adjusting your care.
Clinical care built on incomplete signals.
Current ADHD diagnosis and treatment relies almost entirely on subjective reporting — a methodology that would be considered inadequate in any other chronic condition.
The Questionnaire Problem
"How often does your child seem distracted?" Clinicians receive 6-point Likert scales — recalled, biased, and unverifiable. There is no continuous signal. There is no baseline.
Attention Profile — Reported
Parent/patient recall, past 4 weeks
The Titration Loop
Medication adjustment cycles run 6–12 weeks. Each iteration: new dose, wait, questionnaire, adjust. No intra-day data. No pharmacodynamic curve. Just guesswork with a prescription pad.
Medication Response Curve
Expected vs. captured data points
The Invisible Baseline
Adult patients spend years describing symptoms they cannot prove. "I lose focus." "I can't stop moving." Without objective measurement, providers have no ground truth to treat against.
Fidget Frequency Baseline
Objective measurement — unavailable
"The data has always been there. It was just never captured."
— Dr. Amara Osei-Mensah, Pediatric Neurology, UCSF · Monitor Pilot Investigator
Six sensors. One wrist. Continuous truth.
Monitor was designed from the sensor layer up for clinical-grade data collection in real-world conditions — not a consumer wellness device repurposed for medicine.
Clinical Accuracy
Validated against gold-standard actigraphy (r = 0.94, n = 312) and polysomnography HRV measurement (ICC = 0.91) across three independent sites.
The same questions. Now answered with continuous signal.
Those broken charts from Section 01? Monitor rebuilds them — complete, continuous, and timestamped to the millisecond.
Attention Profile — Continuous
200Hz · 24-hour rolling window
Replaces the sparse questionnaire graph. Every 5-minute interval captured, labeled, and anomaly-flagged.
Medication Response Curve
Onset, peak, washout — measured
Pharmacodynamic curves derived from biometric response — not estimated from dosing schedules.
Fidget Frequency — Hourly
IMU-derived · amber = elevated
Objective fidget events per hour. Amber bars flag medication washout periods — visible to both patient and provider.
The view your psychiatrist sees — before your appointment.
Clinicians access a HIPAA-compliant dashboard updated continuously. Medication decisions arrive informed by weeks of biometric history, not a 10-minute recall.
Patient
Marcus T., 9y
ADHD Combined Type
Current Rx
Methylphenidate 18mg
QAM · Day 23
Provider
Dr. Priya Nambiar
Pediatric Neurology
Next Review
Mar 4, 2026
Titration decision
Attention Index — Last 7 Days
+12%HRV Trend
+11%Fidget Events / Hr
-22%Medication Timing Adherence
87%AI-Assisted Clinical Note · Draft
Patient shows improving attention index (+12% over 7 days) with stable HRV. Fidget frequency declining — consistent with therapeutic response to current titration. Recommend maintaining current dose through next review. Medication washout pattern visible daily 16:00–18:00 — discuss extended-release formulation at appointment.
"For the first time, I can see exactly when the medication is wearing off. I used to guess based on what parents told me."
Dr. Priya Nambiar
Pediatric Neurology · Boston Children's
"The dashboard cut my titration cycle from 8 weeks to 11 days. The data was there — I just finally had access to it."
Dr. James Okafor
Child & Adolescent Psychiatry · Johns Hopkins
"My adult patients cry when they see the chart for the first time. Not because it's bad news — because it's finally real."
Dr. Sonia Mehta
Behavioral Psychiatry · Stanford Medicine
The guesswork era is over. The data says so.
Monitor's methodology is published, peer-reviewed, and independently replicated. This is not a wellness device making wellness claims.
Continuous Wrist Biometrics vs. Parent-Reported ADHD Symptom Severity: A 312-Patient Controlled Trial
r = 0.94 correlation with gold-standard actigraphy; 6× faster titration decisions
DOI: 10.1177/0883073825001234
HRV as a Real-Time Biomarker for Methylphenidate Response in Pediatric ADHD
HRV-derived response curves matched pharmacokinetic modeling in 89% of patients
DOI: 10.1001/jamapsychiatry.2025.0892
Fidget Frequency as an Objective ADHD Severity Marker: IMU-Based Validation Study
ICC = 0.91 vs. video-coded movement analysis; clinically actionable at 200Hz
DOI: 10.1038/s41746-024-01023-7
Regulatory Status
Monitor has received FDA Breakthrough Device Designation (BDD) for its ADHD medication titration support indication — a designation reserved for devices that provide more effective diagnosis or treatment of serious conditions. CE Mark application submitted Q1 2026.
The data is real. The science is published.
Request clinical access for your practice, or join the patient waitlist. Monitor is currently in limited deployment — priority given to pediatric neurology and psychiatry practices.
I am a